Robin L Smith Sorrento Therapeutics, Inc. (SRNE) insider trading activity

SRNE Quotes by TradingView

Robin L Smith is Director of Sorrento Therapeutics, Inc.. Currently has a direct ownership of 235,000 shares of SRNE, which is worth approximately $77,550. The most recent transaction as insider was on Sep 03, 2021, when has been sold 175,000 shares (Common Stock) at a price of $4.42 per share, resulting in proceeds of $773,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 235K
0% 3M change
0% 12M change
Total Value Held $77,550

Robin L Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2021
BUY
Exercise of conversion of derivative security
$773,500 $4.42 p/Share
175,000 Added 42.68%
235,000 Common Stock

Also insider at

CELU
Celularity Inc Healthcare
Director
RLS

Robin L Smith

Director
Florham Park, NJ

Track Institutional and Insider Activities on SRNE

Follow Sorrento Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRNE shares.

Notify only if

Insider Trading

Get notified when an Sorrento Therapeutics, Inc. insider buys or sells SRNE shares.

Notify only if

News

Receive news related to Sorrento Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRNE